David C. Gaston

1.5k total citations
37 papers, 569 citations indexed

About

David C. Gaston is a scholar working on Epidemiology, Infectious Diseases and Clinical Biochemistry. According to data from OpenAlex, David C. Gaston has authored 37 papers receiving a total of 569 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Epidemiology, 14 papers in Infectious Diseases and 7 papers in Clinical Biochemistry. Recurrent topics in David C. Gaston's work include SARS-CoV-2 and COVID-19 Research (7 papers), Bacterial Identification and Susceptibility Testing (7 papers) and Mycobacterium research and diagnosis (6 papers). David C. Gaston is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (7 papers), Bacterial Identification and Susceptibility Testing (7 papers) and Mycobacterium research and diagnosis (6 papers). David C. Gaston collaborates with scholars based in United States, Canada and Australia. David C. Gaston's co-authors include Eili Klein, Heba H. Mostafa, C. Paul Morris, Andrew Pekosz, Nicholas J. Swanson, Jaiprasath Sachithanandham, Maggie Li, Patricia J. Simner, Emily Jacobs and Karen C. Carroll and has published in prestigious journals such as JAMA, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

David C. Gaston

35 papers receiving 566 citations

Peers

David C. Gaston
Melissa Gitman United States
Chia‐Yu Chi Taiwan
David Hassin Israel
Joshua C. Eby United States
Karen P. Acker United States
Vikas Peddu United States
Christian Herzmann Germany
Yufei Song China
Kristina L. Bajema United States
Hannah E. Maier United States
Melissa Gitman United States
David C. Gaston
Citations per year, relative to David C. Gaston David C. Gaston (= 1×) peers Melissa Gitman

Countries citing papers authored by David C. Gaston

Since Specialization
Citations

This map shows the geographic impact of David C. Gaston's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David C. Gaston with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David C. Gaston more than expected).

Fields of papers citing papers by David C. Gaston

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David C. Gaston. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David C. Gaston. The network helps show where David C. Gaston may publish in the future.

Co-authorship network of co-authors of David C. Gaston

This figure shows the co-authorship network connecting the top 25 collaborators of David C. Gaston. A scholar is included among the top collaborators of David C. Gaston based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David C. Gaston. David C. Gaston is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Humphries, Romney M., Ritu Banerjee, William D. Dupont, et al.. (2025). Association Between Blood Culture Bottle Shortage and Ordering Restrictions and Clinical Outcomes for Patients With Staphylococcus aureus Bacteremia. Open Forum Infectious Diseases. 12(9). ofaf546–ofaf546.
2.
3.
Humphries, Romney M., et al.. (2024). Rapid Implementation of Blood Culture Stewardship: Institutional Response to an Acute National Blood Culture Bottle Shortage. Clinical Infectious Diseases. 80(2). 472–474. 6 indexed citations
4.
Chiu, Charles Y., David C. Gaston, Catherine A. Hogan, et al.. (2024). Clinical Metagenomic Next-Generation Sequencing for Diagnosis of Central Nervous System Infections: Advances and Challenges. Molecular Diagnosis & Therapy. 28(5). 513–523. 6 indexed citations
5.
Gaston, David C., et al.. (2023). Diagnostic Stewardship for Next-Generation Sequencing Assays in Clinical Microbiology. Clinics in Laboratory Medicine. 44(1). 63–73. 7 indexed citations
6.
Bloch, Karen C., Carol Glaser, David C. Gaston, & Arun Venkatesan. (2023). Executive Summary: State-of-the Art: Acute Encephalitis. Clinical Infectious Diseases. 77(5). 669–671. 2 indexed citations
7.
Tao, Lili, Romney M. Humphries, Ritu Banerjee, & David C. Gaston. (2023). Re-emergence ofParechovirus: 2017–2022 National Trends of Detection in Cerebrospinal Fluid. Open Forum Infectious Diseases. 10(3). ofad112–ofad112. 4 indexed citations
8.
Esper, Frank, Mary Kathryn Doud, Romney M. Humphries, et al.. (2023). False positive congenital cytomegalovirus saliva screening results with an FDA-approved assay at two institutions. Journal of Clinical Virology. 166. 105527–105527. 4 indexed citations
9.
Hogan, Catherine A., Steve Miller, Anne Piantadosi, et al.. (2023). Which trial do we need? Plasma metagenomic next-generation sequencing to diagnose infections in patients with haematological malignancies and febrile neutropenia: proposal for a randomized-controlled trial. Clinical Microbiology and Infection. 29(12). 1474–1479. 2 indexed citations
10.
Robinson, Matthew L., C. Paul Morris, Joshua Betz, et al.. (2022). Impact of Severe Acute Respiratory Syndrome Coronavirus 2 Variants on Inpatient Clinical Outcome. Clinical Infectious Diseases. 76(9). 1539–1549. 17 indexed citations
11.
Gaston, David C., et al.. (2022). The Brief Case: The Fly Who Cried Wohlf. Journal of Clinical Microbiology. 60(6). e0107321–e0107321. 2 indexed citations
12.
Gaston, David C., Heather B. Miller, John A. Fissel, et al.. (2022). Evaluation of Metagenomic and Targeted Next-Generation Sequencing Workflows for Detection of Respiratory Pathogens from Bronchoalveolar Lavage Fluid Specimens. Journal of Clinical Microbiology. 60(7). e0052622–e0052622. 103 indexed citations
13.
Dioverti, M. Veronica, David C. Gaston, C. Paul Morris, et al.. (2022). Combination Therapy With Casirivimab/Imdevimab and Remdesivir for Protracted SARS-CoV-2 Infection in B-cell-Depleted Patients. Open Forum Infectious Diseases. 9(6). ofac064–ofac064. 18 indexed citations
14.
Gaston, David C., et al.. (2022). Closing the Brief Case: The Fly Who Cried Wohlf. Journal of Clinical Microbiology. 60(6). e0108121–e0108121. 1 indexed citations
15.
16.
Gaston, David C., Maricar Malinis, David R. Peaper, et al.. (2020). Clinical implications of SARS-CoV-2 cycle threshold values in solid organ transplant recipients. American Journal of Transplantation. 21(3). 1304–1311. 16 indexed citations
17.
Gupta, Sumati, Samantha Greenberg, David C. Gaston, et al.. (2017). Inherited DNA repair gene mutations detected by tumor next generation sequencing in urinary tract cancers. Familial Cancer. 16(4). 545–550. 3 indexed citations
18.
Gupta, Sumati, David C. Gaston, Marta E. Heilbrun, et al.. (2017). Comprehensive Genomic Sequencing of Urothelial Tumors Identifies Rare SMARCB1 (INI-1)–Deficient Carcinomas of the Urinary System. Clinical Genitourinary Cancer. 16(2). e373–e382. 5 indexed citations
19.
Gill, David, David C. Gaston, Erin Bailey, et al.. (2017). Efficacy of Eplerenone in the Management of Mineralocorticoid Excess in Men With Metastatic Castration-resistant Prostate Cancer Treated With Abiraterone Without Prednisone. Clinical Genitourinary Cancer. 15(4). e599–e602. 14 indexed citations
20.
Gaston, David C., Li Li, James M. Markert, et al.. (2013). Production of Bioactive Soluble Interleukin-15 in Complex with Interleukin-15 Receptor Alpha from a Conditionally-Replicating Oncolytic HSV-1. PLoS ONE. 8(11). e81768–e81768. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Melissa Gitman Breakdown of academic impact, for papers by Chia‐Yu Chi Breakdown of academic impact, for papers by David Hassin Breakdown of academic impact, for papers by Joshua C. Eby Breakdown of academic impact, for papers by Karen P. Acker Breakdown of academic impact, for papers by Vikas Peddu Breakdown of academic impact, for papers by Christian Herzmann Breakdown of academic impact, for papers by Yufei Song Breakdown of academic impact, for papers by Kristina L. Bajema Breakdown of academic impact, for papers by Hannah E. Maier
Rankless by CCL
2026